Piper Sandler Issues Positive Forecast for Nutrien (NYSE:NTR) Stock Price

Nutrien (NYSE:NTR) had its price target hoisted by stock analysts at Piper Sandler from $58.00 to $63.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Piper Sandler’s target price indicates a potential upside of 18.47% from the company’s current price.

A number of other equities research analysts also recently commented on NTR. Oppenheimer began coverage on Nutrien in a report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 target price for the company. CIBC reissued an “outperformer” rating and set a $55.00 price objective (down previously from $60.00) on shares of Nutrien in a report on Tuesday, December 10th. Barclays reaffirmed an “equal weight” rating and issued a $56.00 target price (up from $55.00) on shares of Nutrien in a report on Tuesday, January 21st. UBS Group lowered Nutrien from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $66.00 to $51.00 in a research note on Thursday, October 10th. Finally, JPMorgan Chase & Co. upgraded Nutrien from an “underweight” rating to a “neutral” rating and upped their price target for the stock from $40.00 to $50.00 in a report on Monday, January 13th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Nutrien has a consensus rating of “Moderate Buy” and a consensus target price of $58.67.

Nutrien Trading Up 0.8 %

NYSE NTR opened at $53.18 on Monday. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $26.11 billion, a P/E ratio of 35.75, a P/E/G ratio of 1.17 and a beta of 0.81. Nutrien has a 52-week low of $43.69 and a 52-week high of $60.87. The firm has a 50-day moving average price of $47.61 and a 200 day moving average price of $47.98.

Nutrien (NYSE:NTR) last issued its earnings results on Wednesday, November 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The business had revenue of $5.35 billion for the quarter, compared to analysts’ expectations of $5.26 billion. During the same period last year, the company posted $0.35 earnings per share. The business’s quarterly revenue was down 5.0% on a year-over-year basis. Equities research analysts expect that Nutrien will post 3.5 EPS for the current year.

Institutional Trading of Nutrien

Hedge funds and other institutional investors have recently bought and sold shares of the company. Central Pacific Bank Trust Division acquired a new stake in shares of Nutrien during the third quarter worth $28,000. HHM Wealth Advisors LLC lifted its position in Nutrien by 331.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 625 shares of the company’s stock worth $28,000 after buying an additional 480 shares during the period. Exchange Traded Concepts LLC lifted its position in Nutrien by 96.7% during the fourth quarter. Exchange Traded Concepts LLC now owns 846 shares of the company’s stock worth $38,000 after buying an additional 416 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Nutrien in the 2nd quarter worth about $52,000. Finally, Union Bancaire Privee UBP SA purchased a new stake in Nutrien in the 4th quarter valued at about $67,000. 63.10% of the stock is owned by hedge funds and other institutional investors.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.